- Home
- ACET vs PRPL Comparison
ACET vs PRPL Comparison
Compare ACET & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACET
- PRPL
- Stock Information
- Founded
- ACET 1947
- PRPL 2010
- Country
- ACET United States
- PRPL United States
- Employees
- ACET N/A
- PRPL N/A
- Industry
- ACET Biotechnology: Pharmaceutical Preparations
- PRPL Home Furnishings
- Sector
- ACET Health Care
- PRPL Consumer Discretionary
- Exchange
- ACET Nasdaq
- PRPL Nasdaq
- Market Cap
- ACET 93.1M
- PRPL 100.6M
- IPO Year
- ACET N/A
- PRPL N/A
- Fundamental
- Price
- ACET $0.96
- PRPL $0.90
- Analyst Decision
- ACET Strong Buy
- PRPL Buy
- Analyst Count
- ACET 4
- PRPL 4
- Target Price
- ACET $5.67
- PRPL $2.53
- AVG Volume (30 Days)
- ACET 790.0K
- PRPL 311.3K
- Earning Date
- ACET 11-06-2024
- PRPL 11-04-2024
- Dividend Yield
- ACET N/A
- PRPL N/A
- EPS Growth
- ACET N/A
- PRPL N/A
- EPS
- ACET N/A
- PRPL N/A
- Revenue
- ACET N/A
- PRPL $504,838,000.00
- Revenue This Year
- ACET N/A
- PRPL N/A
- Revenue Next Year
- ACET N/A
- PRPL $2.21
- P/E Ratio
- ACET N/A
- PRPL N/A
- Revenue Growth
- ACET N/A
- PRPL N/A
- 52 Week Low
- ACET $0.89
- PRPL $0.69
- 52 Week High
- ACET $3.77
- PRPL $2.33
- Technical
- Relative Strength Index (RSI)
- ACET 37.36
- PRPL 45.24
- Support Level
- ACET $0.91
- PRPL $0.89
- Resistance Level
- ACET $1.12
- PRPL $0.99
- Average True Range (ATR)
- ACET 0.09
- PRPL 0.06
- MACD
- ACET 0.00
- PRPL -0.01
- Stochastic Oscillator
- ACET 16.21
- PRPL 9.60
About ACET Adicet Bio Inc.
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its lead product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its lead preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.